About Contura
Contura is a Healthcare company based in London (United Kingdom) founded in 2000, and was acquired by Axonics in February 2021. Generic drugs and hydrogel products are manufactured by Contura. The company has 118 employees. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Contura International Ltd.
Company details
Contura was founded in 2000 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, where generic drugs and hydrogel-based products are produced. Manufacturing processes are centered on developing affordable alternatives to branded medications and specialized medical hydrogels for various applications. The company maintains a presence in the global generics market, with activities spanning production, distribution, and regulatory compliance in Europe.
Investors in Contura
Contura has secured backing from 1 investor. Prominent investors backing the company include Axonics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | axonics.com | Irvine, United States |
Investor details for Contura
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Contura
20 people are tracked at Contura (4 in leadership, 16 in team); the tracked headcount is 118.
| Name | Role | Group |
|---|---|---|
Dorte Birck Elmegaard | Corporate Support HR Manager PA To The CEO | Leadership |
Carina Moldow | RA/R&D Director | Leadership |
Rakesh Tailor | Chief Executive Officer | Leadership |
Ieva Ankorina-Stark | Managing Director/Chief Scientific Officer | Leadership |
Jeff Craven | Principal Medical Writer | Team |
Alina Andersen | Medical Writer | Team |
Kady A. Jessen (Khadijeh) | Quality Assurance Coordinator | Team |
Sandra Isabella Sohn | Process Engineer | Team |
Samir Ben Chaabane | Process Engineer | Team |
Achebe Niels Olesen Nzulumike | Process Engineer | Team |
Gitte Berg Fynholm | Procesingeniør | Team |
Julius Gardarsson | Warehouse Assistant | Team |
Tina Brix Jacobsen | Procesoperatør | Team |
Rico Røder Riis | Process Development Manager | Team |
Anja Christina Kostechy-Skaaning | Supply Chain & IT Manager | Team |
Dines Bennetsen | Operations Manager | Team |
Kristina Saudargyte | QA&RA Coordinator | Team |
Minna Holbech | Project Manager | Team |
Paula Bennett | Office Manager | Team |
Sophie Stæhr | Student Assistant | Team |
Complete people profiles for Contura
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Contura
2 dated milestones of Contura across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Contura is founded.
- Exit Acquired by Axonics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Contura
Contura was founded in 2000.
Contura is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Contura has 118 employees.
Contura was founded in 2000 and is headquartered in London, United Kingdom. Operations focus on the pharmaceutical sector, where generic drugs and hydrogel-based products are produced. Manufacturing processes are centered on developing affordable alternatives to branded medications and specialized medical hydrogels for various applications. The company maintains a presence in the global generics market, with activities spanning production, distribution, and regulatory compliance in Europe.
Contura has 1 investor. Key investors include Axonics.
Contura operates through Contura International Ltd.
Yes. Contura was acquired by Axonics in February 2021.